FierceBiotech coming to iPhone and iPad this fall (sign up for early notification)

FierceBiotech is coming to iPhone and iPad this fall! Get ready to read the news by swiping right-to-left – during development this summer I was delighted how this app made my daily "full read" of FierceBiotech faster by employing a print media reading habit. Reminds me of reading the Wichita Business Journal, except about biotech, not the Air Capital of the World.

Get breaking biotech news alerts, save content to your device for offline reading, share directly by email or your social network of choice. And that's just version 1. Sign up and be the first to know the moment it's available on the App Store.

Sign-up form direct link

Android readers, we're aware you outnumber Apple's, and we're working to launch by year end. 



Suggested Articles

Sanofi is teaming up with Merck while AstraZeneca taps Arcus as the future of cancer work is very much made together.

The action follows the FDA’s decision to reject a filing for approval of the JAK1 inhibitor in rheumatoid arthritis due to toxicity concerns.

The phase 2/3 clinical trial linked REGN-COV2 to a 57% decline in medical visits associated with COVID-19 in the 29 days after treatment.